Hasui K, Ohmoto T, Tamaki T, Fukui K, Iwao H, Abe Y
Department of Neurological Surgery, Kagawa Medical School, Japan.
J Pharmacobiodyn. 1991 Feb;14(2):94-100. doi: 10.1248/bpb1978.14.94.
The present study was designed to determine the regional hemodynamic effects of prolonged beta-adrenergic receptor inhibition in conscious stroke-prone spontaneously hypertensive rats (SHRSP) using a radioactive microsphere method. When the regional blood flow was compared between 10 and 30 weeks of age, the age-related changes in organ blood flow were observed in several organs, i.e., the reduction of flow rate in kidney, adrenal gland and intestines. The reduction of flow rate in these organs contributes strongly to the age-related rise of total peripheral resistance. Carteolol, a beta-adrenoceptor antagonist, was given at a dose of 10 mg/kg/d from 10 to 30 weeks of age. These animals gained more weight than the untreated control SHRSPs, and heart rate was reduced significantly. Blood pressure was not affected. However, the prolonged treatment with carteolol prevented the age-related reduction of the blood flow rate in the kidney, adrenal gland and intestines. Thus, our findings indicate that carteolol had appreciable and beneficial effects on the maintenance of flow rates in the above organs of SHRSP without any change in blood pressure.
本研究旨在使用放射性微球法,确定长期β-肾上腺素能受体抑制对清醒的易患中风自发性高血压大鼠(SHRSP)局部血流动力学的影响。当比较10周龄和30周龄大鼠的局部血流量时,在几个器官中观察到了与年龄相关的器官血流变化,即肾脏、肾上腺和肠道的血流速率降低。这些器官血流速率的降低是总外周阻力随年龄增长而升高的重要原因。从10周龄到30周龄,以10mg/kg/d的剂量给予β-肾上腺素能受体拮抗剂 carteolol。这些动物比未治疗的对照SHRSP体重增加更多,心率显著降低。血压未受影响。然而,长期使用 carteolol 治疗可防止肾脏、肾上腺和肠道血流速率随年龄增长而降低。因此,我们的研究结果表明,carteolol 对维持SHRSP上述器官的血流速率具有显著且有益的作用,而血压无任何变化。